Kymera Therapeutics, Inc 10-Q for FY2021 Q2
Kymera Therapeutics, Inc. (KYMR)
10-Q
2021-08-06
For: 2021-06-30
View Original
Added on
April 10, 2026
About this 10-Q
Kymera Therapeutics, Inc filed this 10-Q on August 6, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).
Headline figures
Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $18.52M
- up 463.2% from $3.29M a year earlier
- Net loss
- $24.66M
- compared with a net loss of $13.99M a year earlier